Menu
Back to Journals » Lung Cancer: Targets and Therapy » Volume 10
Review
Profile of entrectinib and its potential in the treatment of ROS1-positive NSCLC: evidence to date
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 10,834 | Dovepress* | 6,699+ | 1,273 | 7,972 | |
| PubMed Central* | 4,135 | 663 | 4,798 | ||
| Totals | 10,834 | 1,936 | 12,770 | ||
| *Since 9 September 2019 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 2 | 0 | 0 | 1 | 0 | 1 |
View citations on PubMed Central and Google Scholar